Researchers have made a significant breakthrough in understanding how Alzheimer’s disease progresses through the brain. Scientists have identified a common brain protein that functions as a cellular courier, actively transporting toxic Tau protein aggregates from damaged neurons to healthy ones. This discovery fundamentally changes our understanding of Alzheimer’s pathology, revealing that protein spread is not a passive accumulation but rather an active transport process.
The identification of this transport mechanism presents a promising new therapeutic target. By blocking this specific protein’s ability to carry toxic Tau between neurons, researchers believe they can potentially slow or halt disease progression. This discovery offers a new mechanistic approach to developing disease-modifying treatments, moving beyond current symptomatic interventions. The findings suggest that targeting this cellular courier could preserve cognitive function and delay neurodegeneration in Alzheimer’s patients.
Read the full article on GMJ Newsroom.
Was this article helpful?
